What is the significance of China approving the first solid tumor CAR-T therapy?

China’s approval of the first CAR‑T therapy for solid tumors marks a major milestone for cell therapy, which until now had only succeeded in blood cancers. The move signals that technical and regulatory barriers can be overcome, potentially pressuring Western developers to accelerate and reshaping global competition in CAR‑T innovation.